Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Welcome | eleva |
Description | We develop drug candidates to advance into the clinic with pharmaceutical Unlocking the power of complex proteins forfuture therapies. We develop drug candidates to advance into the clinic with pharmaceutical |
Keywords | N/A |
WebSite | elevabiologics.com |
Host IP | 185.243.133.181 |
Location | - |
Site | Rank |
US$7,032,251
Last updated: 2023-05-07 03:45:17
elevabiologics.com has Semrush global rank of 1,505,109. elevabiologics.com has an estimated worth of US$ 7,032,251, based on its estimated Ads revenue. elevabiologics.com receives approximately 811,414 unique visitors each day. Its web server is located in -, with IP address 185.243.133.181. According to SiteAdvisor, elevabiologics.com is safe to visit. |
Purchase/Sale Value | US$7,032,251 |
Daily Ads Revenue | US$6,492 |
Monthly Ads Revenue | US$194,740 |
Yearly Ads Revenue | US$2,336,871 |
Daily Unique Visitors | 54,095 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
elevabiologics.com. | A | 86399 | IP: 185.243.133.181 |
elevabiologics.com. | NS | 3600 | NS Record: ns73.domaincontrol.com. |
elevabiologics.com. | NS | 3600 | NS Record: ns74.domaincontrol.com. |
elevabiologics.com. | MX | 600 | MX Record: 10 elevabiologics-com.mail.protection.outlook.com. |
elevabiologics.com. | TXT | 86400 | TXT Record: v=spf1 include:spf.protection.outlook.com include:spf.nl2go.com-all include:amazonses.com ~all |
LATEST NEWS Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H Björn Cochlovius New CEO of Eleva Assets Complement Enzyme replacement therapies Platform Publications Company Careers Newsroom Contact Imprint Unlocking the power of complex proteins for future therapies Unlocking the power of complex proteins for future therapies Mission We develop drug candidates to advance into the clinic with pharmaceutical partners New solutions and new therapies need new avenues to reach them. The age of cells producing biological compounds has achieved a lot for human medicine, but its means are coming to an end. A step change in technology is required to unleash the potential of molecules we didn’t dream we would discover – or be able to create if we did. ELEVA is opening this realm of unprecedented therapies with the help of an inconspicuous but incredibly efficient tool: Bryophyta, more commonly known as moss. This ancient organism holds the key to the |
HTTP/1.1 301 Moved Permanently Date: Wed, 27 Oct 2021 06:35:47 GMT Server: Apache Location: https://elevabiologics.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 301 date: Wed, 27 Oct 2021 06:35:47 GMT server: Apache location: https://www.elevabiologics.com content-type: text/html; charset=iso-8859-1 HTTP/2 200 date: Wed, 27 Oct 2021 06:35:47 GMT server: Apache last-modified: Tue, 26 Oct 2021 23:11:40 GMT cache-control: max-age=0 expires: Wed, 27 Oct 2021 06:35:47 GMT vary: Accept-Encoding content-type: text/html; charset=UTF-8 |
Domain Name: ELEVABIOLOGICS.COM Registry Domain ID: 2521959413_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.meshdigital.com Registrar URL: http://www.meshdigital.com Updated Date: 2021-04-04T12:23:59Z Creation Date: 2020-05-04T12:47:11Z Registry Expiry Date: 2022-05-04T12:47:11Z Registrar: Mesh Digital Limited Registrar IANA ID: 1390 Registrar Abuse Contact Email: abuse@domainbox.com Registrar Abuse Contact Phone: +18779770099 Domain Status: ok https://icann.org/epp#ok Name Server: NS73.DOMAINCONTROL.COM Name Server: NS74.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T04:17:12Z <<< |